GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
3

3SBio 1530.HK · HKD

Health Care · HKEX · 🇭🇰 Hong Kong

Compare

15.16

-0.13%

Close of 9 Nov 2026, in HKD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CNY, from our data supplier.

FY2025

Revenue

CN¥20.61bn

FY2016FY2025

Net income

CN¥9.88bn

FY2016FY2025

Free cash flow

CN¥10.63bn

FY2016FY2025

Shareholders' equity

CN¥31.70bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueCN¥20.61bnCN¥10.61bnCN¥9.10bnCN¥7.99bnCN¥7.43bnCN¥6.51bnCN¥6.19bnCN¥5.34bnCN¥4.35bnCN¥3.26bn
Gross profitCN¥19.04bnCN¥9.12bnCN¥7.73bnCN¥6.60bnCN¥6.14bnCN¥5.27bnCN¥5.12bnCN¥4.32bnCN¥3.56bnCN¥2.79bn
Research and developmentCN¥1.77bnCN¥1.54bnCN¥925.5mCN¥807.2mCN¥877.9mCN¥687.5mCN¥613.2mCN¥422.4mCN¥299.6mCN¥283.0m
Operating incomeCN¥12.28bnCN¥3.04bnCN¥2.86bnCN¥2.41bnCN¥2.13bnCN¥1.70bnCN¥1.56bnCN¥1.42bnCN¥1.35bnCN¥1.06bn
Net incomeCN¥9.88bnCN¥2.43bnCN¥1.80bnCN¥2.23bnCN¥1.92bnCN¥973.3mCN¥1.13bnCN¥1.49bnCN¥1.09bnCN¥829.8m
Diluted earnings per share3.970.970.740.850.690.380.450.540.400.32

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsCN¥42.23bnCN¥28.20bnCN¥27.51bnCN¥25.61bnCN¥22.37bnCN¥20.59bnCN¥17.25bnCN¥16.12bnCN¥16.02bnCN¥12.85bn
Cash and short-term investmentsCN¥22.97bnCN¥6.75bnCN¥6.98bnCN¥8.16bnCN¥5.48bnCN¥5.08bnCN¥2.98bnCN¥2.17bnCN¥3.61bnCN¥1.21bn
Total liabilitiesCN¥6.77bnCN¥7.19bnCN¥8.28bnCN¥7.67bnCN¥5.30bnCN¥5.34bnCN¥5.18bnCN¥5.74bnCN¥7.13bnCN¥4.98bn
DebtCN¥3.00bnCN¥3.55bnCN¥4.84bnCN¥4.52bnCN¥2.63bnCN¥2.91bnCN¥2.81bnCN¥3.29bnCN¥4.41bnCN¥3.06bn
Shareholders' equityCN¥31.70bnCN¥17.98bnCN¥16.34bnCN¥15.10bnCN¥14.24bnCN¥12.45bnCN¥11.21bnCN¥10.03bnCN¥8.61bnCN¥7.60bn
Shares outstanding2,486m2,501m2,440m2,623m2,774m2,544m2,540m2,741m2,735m2,583m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsCN¥11.26bnCN¥3.73bnCN¥2.43bnCN¥2.54bnCN¥1.84bnCN¥1.57bnCN¥2.20bnCN¥1.34bnCN¥1.25bnCN¥1.17bn
Capital spending−CN¥630.4m−CN¥1.12bn−CN¥820.2m−CN¥1.13bn−CN¥1.33bn−CN¥1.14bn−CN¥566.2m−CN¥504.7m−CN¥283.1m−CN¥542.7m
Free cash flowCN¥10.63bnCN¥2.61bnCN¥1.61bnCN¥1.41bnCN¥503.7mCN¥422.8mCN¥1.63bnCN¥834.7mCN¥967.7mCN¥626.8m
Dividends paid−CN¥651.9m−CN¥646.4m−CN¥261.9m−CN¥485.8m——−CN¥19.0m−CN¥175.6m−CN¥175.6m−CN¥175.6m

Latest quarters

By quarter end

Jun 2026Dec 2025Jun 2025Dec 2024Jun 2024Dec 2023Jun 2023Dec 2022
RevenueCN¥5.20bnCN¥15.53bnCN¥5.07bnCN¥5.49bnCN¥5.11bnCN¥4.70bnCN¥4.41bnCN¥4.39bn
Gross profitCN¥4.36bnCN¥14.71bnCN¥4.33bnCN¥4.69bnCN¥4.42bnCN¥4.01bnCN¥3.73bnCN¥3.62bn
Operating incomeCN¥1.88bnCN¥10.80bnCN¥1.48bnCN¥1.31bnCN¥1.78bnCN¥1.23bnCN¥1.52bnCN¥1.20bn
Net incomeCN¥1.32bnCN¥8.30bnCN¥1.58bnCN¥1.16bnCN¥1.27bnCN¥662.2mCN¥1.14bnCN¥1.10bn
Diluted earnings per share0.513.340.640.470.510.270.470.42
Cash from operations—CN¥10.18bnCN¥1.16bnCN¥2.46bnCN¥1.27bnCN¥1.05bnCN¥1.38bnCN¥1.29bn
Capital spending—−CN¥373.0m−CN¥110.0m−CN¥513.0m−CN¥280.0m−CN¥350.0m−CN¥376.0m−CN¥746.0m
Free cash flow—CN¥9.81bnCN¥1.05bnCN¥1.94bnCN¥992.0mCN¥696.0mCN¥1.00bnCN¥542.0m
Total assetsCN¥41.42bnCN¥42.23bnCN¥27.75bnCN¥28.20bnCN¥27.89bnCN¥27.51bnCN¥26.98bnCN¥25.61bn
Cash and short-term investmentsCN¥20.49bnCN¥22.97bnCN¥7.52bnCN¥6.75bnCN¥6.73bnCN¥6.98bnCN¥7.77bnCN¥8.16bn
DebtCN¥721.5mCN¥3.00bnCN¥2.18bnCN¥4.14bnCN¥4.91bnCN¥5.63bnCN¥5.79bnCN¥5.26bn
Shareholders' equityCN¥32.04bnCN¥31.70bnCN¥19.00bnCN¥17.98bnCN¥16.75bnCN¥16.34bnCN¥15.75bnCN¥15.10bn

Financial ratios

Data as of 17 Sept 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin92.4%86.0%85.0%82.7%82.7%81.0%
Operating margin59.6%28.7%31.5%30.2%28.6%26.2%
Net margin47.9%23.0%19.8%27.9%25.9%15.0%
Return on equity31.2%13.5%11.0%14.8%13.5%7.8%
Return on assets23.4%8.6%6.6%8.7%8.6%4.7%
Free cash flow yield25.8%10.4%7.2%7.5%6.2%5.7%
Revenue growth94.3%16.5%13.9%7.5%14.2%5.1%
Earnings growth305.8%34.9%-19.1%16.0%97.6%-14.2%
Current ratio5.13x1.71x2.47x5.44x5.49x4.60x
Debt to equity0.09x0.23x0.34x0.35x0.21x0.27x
Equity ratio75.1%63.8%59.4%59.0%63.6%60.5%
Interest coverage141.72x13.68x11.58x20.14x27.45x18.03x
R&D as a share of sales8.6%14.6%10.2%10.1%11.8%10.6%
Buybacks as a share of market value0.6%-2.5%7.0%5.4%-9.0%-0.1%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue37.1%25.9%26.6%
Operating income72.1%48.5%36.2%
Net income64.2%59.0%32.0%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin90.2%88.0%86.6%85.6%
Operating margin49.1%42.6%39.2%36.4%
Net margin39.4%33.8%30.9%29.3%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings5.35.58.98.68.316.319.916.333.920.7
Price to sales2.61.31.82.42.12.43.64.58.55.3

Dividends and splits

Per share, in the currency the company pays

Paid for 4 years. Last went ex-dividend on 21 Jul 2026.

FY2026FY2025FY2024FY2023FY2022FY2018
Paid in the year0.2160.250.250.100.200.069

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.